Intensity Therapeutics, Inc. (INTS) Ownership
INTS ownership summary
as of October 18, 2026- Institutions
- 35.6% of shares outstanding
- Insiders
- 3.92% of shares outstanding
- Shares outstanding
- 3.3M
- Float
- 3.0M shares available to trade
- Short interest
- 1.22% 38K shares short
- Days to cover
- 2.55 short interest up 22.2% vs prior month
- Institutions 35.56%
- Insiders 3.92%
- Other investors 60.52%
INTS top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Kingsbury Capital Investment Advisors LLC | 15.21% | 496K | $1.7M | +458,439 (+1,204.7%) | June 30, 2026 |
| 2 | KMT WEALTH MANAGEMENT, LLC | 15.21% | 496K | $1.7M | +496,493 (0.0%) | June 30, 2026 |
| 3 | Sentinus, LLC | 0.82% | 27K | $89,522 | +3,429 (+14.7%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 0.81% | 27K | $89,006 | +9,728 (+57.8%) | June 30, 2026 |
| 5 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 0.77% | 25K | $83,750 | — | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.70% | 23K | $76,336 | −3,232 (−12.4%) | June 30, 2026 |
| 7 | Mesirow Fin Investmt Mgmt Intl Equity | 0.43% | 14K | $47,295 | — | June 30, 2026 |
| 8 | Vanguard Fiduciary Trust Co | 0.28% | 9,121 | $30,555 | — | June 30, 2026 |
| 9 | Tower Research Capital LLC | 0.06% | 1,984 | $6,646 | +1,917 (+2,861.2%) | June 30, 2026 |
| 10 | Goss Wealth Management LLC | 0.04% | 1,148 | $3,846 | — | June 30, 2026 |
| 11 | Advisor Group Holdings, Inc. | 0.01% | 200 | $670 | — | June 30, 2026 |
| 12 | Mercer Global Advisors Inc. | <0.01% | 48 | $161 | +48 (0.0%) | June 30, 2026 |
| 13 | Barclays PLC | <0.01% | 42 | $141 | +42 (0.0%) | June 30, 2026 |
| 14 | Morgan Stanley - Brokerage Accounts | <0.01% | 20 | $67 | — | June 30, 2026 |
| 15 | Caitong International Asset Management Co., Limited. | <0.01% | 6 | $20 | +6 (0.0%) | June 30, 2026 |
| 16 | UBS Group AG | 0.00% | 1 | $3 | −191 (−99.5%) | June 30, 2026 |
| 17 | State Street Corp | 0.00% | — | — | −5,448 (−100.0%) | March 31, 2026 |
| 18 | Jane Street Group LLC | 0.00% | — | — | −2,510 (−100.0%) | March 31, 2026 |
| 19 | Warberg Asset Management LLC | 0.00% | — | — | −2,760 (−100.0%) | March 31, 2026 |
| 20 | Wells Fargo & Co | 0.00% | — | — | −200 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 970K shares and 6 cut 14K.
INTS top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.36% | 12K | $39,091 | −63 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | 0.10% | 3,245 | $10,871 | — | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.09% | 3,092 | $10,358 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
INTS shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns INTS
Institutional investors own 35.6% of Intensity Therapeutics's shares and insiders 3.92%. The largest holder is Kingsbury Capital Investment Advisors LLC with 15.21% of the shares (496K), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 6 reduced their stake in the latest filings. Short interest is 1.22% of the float, or 2.55 days of average trading volume. The share count rose 1,750.8% since 2020.
Related: INTS analyst forecast, INTS key metrics. See the INTS stock overview for the latest quote and news.
INTS ownership FAQ
Who owns the most Intensity Therapeutics stock?
The largest shareholders of Intensity Therapeutics are Kingsbury Capital Investment Advisors LLC (15.21%), KMT WEALTH MANAGEMENT, LLC (15.21%), Sentinus, LLC (0.82%), Vanguard Capital Management, LLC (0.81%), NANO CAP NEW MILLENNIUM GROWTH FUND L P (0.77%).
What percentage of Intensity Therapeutics is owned by institutions?
Institutions hold 35.6% of Intensity Therapeutics's shares outstanding; insiders hold 3.92%.
Which funds own Intensity Therapeutics?
The largest fund holders of Intensity Therapeutics are Fidelity Extended Market Index (0.36%), Fidelity Series Total Market Index (0.10%), Fidelity Total Market Index (0.09%).
What is Intensity Therapeutics's short interest?
38K shares of Intensity Therapeutics were sold short, 1.22% of the float; at the average daily volume it would take 2.55 days to cover.
How many shares of Intensity Therapeutics are outstanding?
Intensity Therapeutics has 3.3M shares outstanding, of which 3.0M are in the public float.